Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals
  • Print
  • Share
  • E-mail
-
Generic Name: 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; (1E,6E)-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione
Date Designated: 02/27/2024
Orphan Designation: Treatment of patients with Dercum's disease (adiposis dolorosa)
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Caliway Biopharmaceuticals Co., Ltd.
32F-9, No.99, Sec. 1, Xintai 5th Rd.
Xizhi Dist.
New Taipei City 221
Taiwan

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-